Salute e Benessere

Clinical Trial Shows Pycnogenol® Significantly Relieves Lipedema Symptoms and…

Lipedema is a chronic and often misunderstood condition that affects about 400 million women globally. It causes an abnormal and painful buildup of fat, most often in the legs, hips and buttocks. It is frequently mistaken for obesity or lymphedema, often delaying diagnosis and leaving many women without effective treatment options. Lipedema is a chronic and often misunderstood condition that affects about400 million women globally. It causes an abnormal and painful buildup of fat, most often...
PR Newswire
09/12/2025

Clarins launches its mobile app to elevate its customer relationship, in…

Unlocking a more advanced shopping journey for loyal customers Unlocking a more advanced shopping journey for loyal customers For 70 years, Clarins has built its growth on listening, advising, and staying close to its customers, both in institutes and points of sale. The Clarins app extends this relationship thanks to native features that better address customers' expectations: During the pilot in the UK, nearly 30% of Clarins' loyal customers adopted the app, which received a 4...
PR Newswire
09/12/2025

Leica Biosystems Expands Clinical Digital Pathology Portfolio with Multiple…

Building on the world-leading Aperio GT 450 DX scanner, the Aperio GT 180 DX scanner delivers excellent image quality and speed in a design that works for mid-volume laboratories. In addition, the new Aperio CS5 DX scanner provides 1x3 inch and 2x3 inch slide scanning, with the option for DICOM or SVS image format output. The complete range of clinical scanning solutions enables pathology laboratories to choose the right scanner for their needs, with the confidence of proven Aperio quality and…
PR Newswire
09/12/2025

MINISO Launches First Italian Collectible Toy Store in Milan's Corso Buenos…

Inside the store, more than 200 curated products line the shelves, from popular vinyl plush blind boxes and other themed blind boxes to plush toys and bag charms. The selection brings together some of the most sought-after licensed IPs from China and around the world, including fan favorites from Disney, such as Toy Story and Stitch, as well as Sanrio characters, Care Bears and One Piece. Among the launch highlights, MINISO's Zootopia-themed collection made its first-ever appearance in Italy…
PR Newswire
09/12/2025

Fitasy Unveils Breakthrough Technology Making Custom-Fit 3D Printed Shoes More…

Fitasy's solution integrates proprietary spatial AI, advanced imaging, and digital light projection 3D printing into a seamless scan-to-print workflow. Using only a smartphone, customers capture a full 360-degree model of their feet in both weight-bearing and relaxed positions, recording true geometry with market-leading precision. Fitasy's software then generates a personalized fit profile based on individual foot morphology, enabling shoes to be printed to the exact contours of each foot. ...
PR Newswire
09/12/2025

Fibrocor Therapeutics appoints world-leading nephrologists to Clinical Advisory…

Alport Syndrome is a rare genetic kidney disease characterized by progressive fibrosis that leads to declining kidney function and often renal failure, requiring dialysis or transplantation from early adulthood. It can also cause hearing loss and eye abnormalities. No approved disease-modifying treatments exist. Despite being classified as a rare disease, it affects an estimated 360,000 people across the top 16 global markets, including around 60,000 in the US. Alport Syndrome is a rare…
PR Newswire
09/12/2025

Four NHS trusts boost collaboration with Sectra's cloud service to deliver…

The four NHS Trusts, Blackpool Teaching Hospitals, East Lancashire Hospitals, Lancashire Teaching Hospitals, and University Hospitals of Morecambe Bay, are located in Lancashire and South Cumbria in the UK and deliver care from 15 sites to around 1.8 million people across the region. Three of them have used Sectra's solutions for several years, and all four will now consolidate their radiology imaging and breast imaging into Sectra One Cloud. As Sectra One Cloud is a fully managed cloud service…
PR Newswire
09/12/2025

Sweden Recommends: A Dose of Northern Lights Therapy

With interest in "northern lights travel" on the rise and 61% of travelers naming the aurora borealis as the top natural phenomenon they want to experience, the timing couldn't be better. A rare solar maximum is underway, making aurora displays brighter, more frequent and easier to catch. Sweden offers front-row access to one of nature's most powerful mood boosters. With interest in "northern lights travel" on the rise and61% of travelersnaming the aurora borealis as the top…
PR Newswire
09/12/2025

Leqembi included in China's commercial insurance innovative drug list

Eisai estimates that there were 17 million patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease in China in 2024, which is expected to increase with the aging of the population. Eisai estimates that there were 17 million patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease inChinain 2024, which is expected to increase with the aging of the population. Eisai launched Leqembi inChinainJune 2024and has...
PR Newswire
09/12/2025

Acute on Chronic Liver Failure Market Set to Grow by 2034 as Novel Therapeutic…

Acute on Chronic Liver Failure Market Summary Acute on Chronic Liver Failure Market Summary Discover the acute on chronic liver failure new treatment @New Treatments for Acute on Chronic Liver Failure Key Factors Driving the Growth of the Acute on Chronic Liver Failure Market Rising Chronic Liver Disease Prevalence The increasing prevalence of chronic liver diseases such as cirrhosis, alcoholic liver disease, hepatitis (B and C), and MAFLD is leading to a larger pool...
PR Newswire
08/12/2025

Cereno Scientific Receives FDA Clearance to Initiate Global Phase IIb Trial of…

The Phase IIb trial is formally titled "A Phase 2b, Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Study, to Compare the Efficacy and Safety/Tolerability of CS1 Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)." It is a global, multicenter trial enrolling approximately 126 patients with PAH who are stable on background therapy. During the first 36 weeks of treatment, participants will be randomized to receive…
PR Newswire
08/12/2025

With Child Deaths Projected to Rise for the First Time in a Century, Gates…

Event held in partnership with the Mohamed bin Zayed Foundation for Humanity highlights urgency, honors leadership, and showcases champions advancing progress despite historic global funding cuts Event held in partnership with the Mohamed bin Zayed Foundation for Humanity highlights urgency, honors leadership, and showcases champions advancing progress despite historic global funding cuts ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- At Goalkeepers Abu Dhabi, leaders from...
PR Newswire
08/12/2025

EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of…

The study systematically evaluates teriparatide and several theoretical or observed impurities using the orthogonal methods of EpiVax's PANDA approach: in silico assessment (leveraging T-cell epitope prediction and characterization tools, EpiMatrix® and JanusMatrix®), in vitro HLA binding assays, and human T-cell assays. The study systematically evaluates teriparatide and several theoretical or observed impurities using the orthogonal methods of EpiVax's PANDA approach: in silico assessment...
PR Newswire
08/12/2025

Menarini Group Presents Elacestrant (ORSERDU®) Phase 2 Combination Data in…

The ELEVATE data to be presented at SABCS demonstrate that elacestrant in combination with everolimus or with abemaciclib shows a consistent PFS benefit, irrespective of ESR1 mutation status in patients with ER+/HER2- mBC, who experience disease progression on endocrine therapy (ET), with or without prior exposure to CDK4/6 inhibitors. These updated results also show that the safety of the combinations are consistent with the known safety profiles of each targeted therapy plus standard of…
PR Newswire
08/12/2025

Global Power Tools Market on Track to Reach USD 67.5 Billion by 2035 as Smart…

Industry Transformation Accelerates Through 2035 Industry Transformation Accelerates Through 2035 Between 2025 and 2030, globalpower tool demand is set to climb from USD 39.5 billiontoUSD 52.4 billion , a significant phase marked by strong uptake of battery-powered tools, heightened construction activity, and rapid modernization of production facilities. The decade's second half (2030–2035) will accelerate even further, driven by: As industries seek safer, faster, and more...
PR Newswire
08/12/2025

Clinical Communication & Collaboration Market worth $5,302.9 million by 2030 |…

Clinical Communication & Collaboration Market Size & Forecast: Clinical Communication & Collaboration Market Size & Forecast: Clinical Communication & Collaboration Market Trends & Insights: Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=118830286 The global clinical communication and collaboration market is witnessing robust growth, driven by the increasing need for real-time information exchange, coordinated care delivery, and...
PR Newswire
08/12/2025

Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in…

In the Stage 1 efficacy population (N=18), ofirnoflast achieved a 72% hematologic improvement-erythroid (HI-E) response rate following ≥16 weeks of therapy. Consistent improvements were observed across WHO morphologic subtypes and somatic mutation categories, supporting a broad and biology-driven mechanism of action. In the Stage 1 efficacy population (N=18), ofirnoflast achieved a 72% hematologic improvement-erythroid (HI-E) response rate following ≥16 weeks of therapy. Consistent…
PR Newswire
08/12/2025

EQT portfolio company Colisée to change ownership

During EQT's ownership, Colisée expanded from 270 to almost 400 facilities. EQT supported significant investments in staff training, facility maintenance, digital systems and other initiatives to improve the quality of care and services. The Company also accelerated its sustainability efforts, becoming the first nursing home operator in France to adopt the status of entreprise à mission and introducing rigorous quality evaluation and monitoring frameworks, resulting in validated near-term…
PR Newswire
08/12/2025

Exosomes Market Led by North America with 53% Revenue Share and Global Market…

Emerging Market Trends Emerging Market Trends Rise in Exosome-Based Diagnostics The global shift toward minimally invasive diagnostic tools has significantly boosted the development of exosome-powered assays. These vesicles are increasingly being used to detect biomarkers associated with oncology, neurodegenerative diseases, and metabolic disorders. Diagnostic applications lead current market adoption, supported by their ability to provide high-fidelity molecular insights from blood...
PR Newswire
08/12/2025

Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple…

Servier recently announced that Voranigo ®also won thePrix GalienUSAAward in the Best Product for Orphan/Rare Diseases category, as well as thePrix Galien Poland Award. ThePrix GalienAward recognizes breakthrough products and outstanding research teams across the pharmaceutical, biotech, medtech, and digital health fields. "We are truly honored to receive these prestigious distinctions in several countries. It recognizes the scientific progress that Voranigo®...
PR Newswire
08/12/2025

Therme Group acquires full Thermengruppe Josef Wund portfolio through Therme…

This integration marks an important milestone for Therme Group and its founder, Dr. Robert Hanea, reflecting a long-standing partnership with the late Josef Wund, the Wund family and the Foundation. With full stewardship of all four destinations, Therme Group will lead their next phase of development as part of its global strategy to expand next-generation wellbeing infrastructure and to strengthen the role these destinations play in their local communities. This integration marks an…
PR Newswire
08/12/2025

The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025…

The BRAVO study (Bladder Cancer Recurrence Analysis in Veterans and Outcomes) is a propensity score matched, retrospective analysis evaluating outcomes following BLC compared to WLC alone in 622 patients from the Veterans Affairs Healthcare System. The primary objective was to determine the difference in total healthcare costs over 1, 2, and 5-year intervals with available cost data. A cost-offset analysis was performed addressing multiple aspects of BLC healthcare costs including the financial…
PR Newswire
08/12/2025

HCMCT Manipal Hospitals Delhi, India performs lifesaving heart transplant on a…

Following a month-long critical wait, a compatible donor heart became available from a private hospital in Gurugram, which was transplanted into the patient by renowned surgeon Dr. Yugal Kishore Mishra, Chairman - Manipal Institute of Cardiac Sciences and Chief Cardiovascular Surgeon, Delhiand his team. A green corridor ensured the donor heart reached the hospital within the safe window, and the complex surgical procedure completed in 3 hours and 20 minutes and the new heart began beating…
PR Newswire
08/12/2025

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox…

Mpox is mainly classified into two strains/clades, and infection rates and disease severity vary depending on the type. Locally, diagnostic systems currently available for identifying the clades remain insufficient, and developing simple and rapid diagnostic tests with clade distinguishing capabilities is urgently needed to prevent the further spread of infection. Mpox is mainly classified into two strains/clades, and infection rates and disease severity vary depending on the type. Locally,...
PR Newswire
08/12/2025
Altri  Comunicati